ArticleDEN open2026
Endoscopic Ultrasound-Guided Hepaticogastrostomy With Plastic Stents in Comparison to Transpapillary Drainage With Metallic Stents for Unresectable Malignant Distal Biliary Obstructions.
Article in DEN open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Endoscopic ultrasound-guided hepaticogastrostomy (EUS-HGS) is usually performed for unresectable malignant distal biliary obstruction (MDBO) when endoscopic retrograde cholangiopancreatography-guided biliary stenting with fully covered self-expandable metallic stents (EBS-MSs) fails. We aimed to clarify the clinical outcomes of EUS-HGS with plastic stents (HGS-PSs) compared to EBS-MS. Methods: We retrospectively reviewed patients who underwent either HGS-PS with or without antegrade stenting using MS (AS-MS) or EBS-MS as initial biliary drainage for unresectable MDBO between January 2017 and July 2024. Results: A total of 27 patients were included in the HGS-PS group, and 128 patients were included in the EBS-MS group. Median procedure time was significantly shorter for the HGS-PS group (24 vs. 39 min, Conclusions: Although TRBO tended to be shorter for HGS-PS compared to EBS-MS, the addition of AS-MS to HGS-PS led to comparable TRBO, suggesting that this combination may be a viable alternative. Clinical Trial Registration: The authors have confirmed clinical trial registration is not needed for this submission.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.